HalioDx
Veracyte to Acquire HalioDx for €260M
Veracyte said the acquisition will help accelerate its in vitro diagnostic test development and manufacturing operations in Europe.
OncoDNA Inks Contract With HalioDx to Expand Pharma Testing Services Into North America
HalioDx operates a CLIA-certified lab through which OncoDNA will provide it molecular testing services to drugmakers studying precision cancer therapies.
HalioDx Signs Brazilian Distribution Deal for Colon Cancer Risk Test
The test, called Immunoscore, is designed to predict the risk of relapse in early-stage colon cancer by measuring host immune responses at tumor sites.
HalioDx, FFCD Collaborate for Phase II Metastatic Colorectal Cancer Trial
HalioDx's Immunoscore test, which measures host immune response at the tumor site, will be used to select patients for the trial.
HalioDx, Kite Pharma Extend Biomarker Collaboration
The extended deal covers multiple blood cancer and solid tumor indications and will leverage several HalioDx technologies and approaches.